Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-04

Clinical Trial Update: Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR [Phase 2]

View source ↗

Summary

This Phase 2 trial compared CE-Budesonide Nasal Solution to Rhinocort Aqua for seasonal allergic rhinitis and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CE-Budesonide Nasal Solution (budesonide)
  • Rhinocort Aqua (budesonide nasal spray)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED